Table 1 Participant characteristics
From: Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis
GCA (n = 23) | Controls (n = 27) | |
|---|---|---|
Age [years] | 75.3 ± 8.8 | 68.1 ± 6.0 |
Sex Female (%) Male (%) | 12 (52.2%) 11 (47.8%) | 14 (51.9%) 13 (48.1%) |
Medical history: | ||
Obesity (%) | 2 (8.7) | 9 (33.3) |
Hypertension (%) | 14 (60.9) | 10 (37.0) |
Diabetes (%) | 3 (13) | 0 (0) |
Atherosclerosis (%) | 7 (30.4) | 15 (55.6) |
Neurodegenerative conditions (%) | 0 (0) | 0 (0) |
BCVA (study eye) [logMAR units] | 0.83 ± 0.25 | 0.88 ± 0.20 |
Foveal GCL volume [mm³] | 0.02 ± 0.01 | 0.01 ± 0.01 |
Global pRNFL thickness [µm] | 94.5 ± 17.0 | 92.7 ± 6.3 |
Superficial retinal plexus macular vessel density | 0.24 ± 0.05 | 0.24 ± 0.04 |
Deep retinal plexus macular vessel density | 0.16 ± 0.02 | 0.15 ± 0.02 |